HOME >> BIOLOGY >> NEWS
Whitehead Study Supports Existence Of Ancient RNA World, Helps Provide Insight Into Early Evolution Of Life

For decades, many researchers thought that ribonucleic acid, or RNA, was nothing more than a molecular interpreter that helps translate DNA codes into proteins. But research over the past 15 years, including studies at the Whitehead Institute, has been lending credence to the notion of a so-called "RNA world," an era in early evolution when all life forms were based on RNA.

This view faced a difficulty, however. For RNA-based life to survive, it must have acquired the ability to synthesize its own building blocks, and until now, scientists had not found an RNA molecule with this key characteristic.

In this week's issue of Nature, Drs. David Bartel and Peter Unrau of the Whitehead Institute report that they have found an RNA molecule capable of making a nucleotide building block, providing some of the strongest evidence yet to support the RNA world view. In contemporary metabolism, protein enzymes catalyze this nucleotide-synthesis reaction, which involves the addition of a nucleotide base to a sugar phosphate. For the RNA world scenario to be feasible, scientists had to show that RNA molecules could catalyze this reaction without the help of protein enzymes.

The Bartel lab finding provides this evidence and supports the theory that in early evolution, RNA molecules carried out functions now considered to be the domains of DNA and proteins: like DNA in modern biology, RNA stored the genetic information to reproduce, and like protein, RNA synthesized the molecules needed to reproduce.

These and other findings will ultimately help evolutionary biologists address questions about how life began on earth more than three billion years ago.

Theories about the origins of life have long intrigued scientists and lay people alike. "A fundamental question about the origin of life is what class of molecules gave rise to some of the earliest life forms" says Dr. Bartel.

For years, scientis
'"/>

Contact: Seema Kumar
kumar@wi.mit.edu
(617) 258-6153
Whitehead Institute for Biomedical Research
16-Sep-1998


Page: 1 2 3

Related biology news :

1. Whitehead press seminar 2001: new horizons in the post-genome world
2. Whitehead Institute receives National Science Foundation grant to sequence Neurospora
3. Whitehead press seminar: Beyond the scientific frontier
4. Millennium and the Whitehead Institute identify novel protein important in fat absorption
5. Whitehead Receives $35 Million Grant From National Human Genome Research Institute (NHGRI)
6. Whitehead Receives $7 million NIH Grant To Build High-Speed Sequencing Machines
7. Whitehead Study Establishes Role Of DNA Methylation In The Stability Of DNA, Suggests Possible Role Of Undermethylation In Cancer
8. Study: Emission of smog ingredients from trees is increasing rapidly
9. Study explores gene transfer to modify underlying course of Alzheimers disease
10. Study reveals why eyes in some paintings seem to follow viewers
11. Study by Israeli scientists provides insight on DNA code

Post Your Comments:
(Date:8/6/2015)... , Aug. 6, 2015 Synaptics Inc. ... human interface solutions, today announced collaboration with Microsoft ... Windows 10. Microsoft leveraged Synaptics, deep expertise in ... system. Through stringent testing, Synaptics, ... certified with Microsoft,s Precision TouchPad (PTP) specification empowering ...
(Date:8/5/2015)... MOUNTAIN VIEW, Calif. , Aug. 5, 2015 /PRNewswire/ ... it exhibits continuous growth in applications, penetration into newer ... year after year. The global biosensors space has seen ... having exited the market so far. (Photo ... from Frost & Sullivan, Analysis of the Global ...
(Date:8/3/2015)... SAN JOSE, Calif. , Aug. 3, 2015 /PRNewswire/ ... developer of human interface solutions, today announced that members ... investment community at the Pacific Crest Global Technology Leadership ... Mountain Time. The conference will be held at the ... The presentation may include forward-looking information. ...
Breaking Biology News(10 mins):Synaptics Chosen for Human Interface Co-Development on Windows 10 2Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4
(Date:8/28/2015)... -- According to a new market research ... Thawing Equipment, Alarms), by Biospecimen (Human Tissue, Stem Cells, ... - Global Forecast to 2020", published by MarketsandMarkets, the ... Million by 2020 from USD 2,150.48 Million in 2015, ... 2020. Browse 74 Tables and 95 ...
(Date:8/28/2015)... 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: ... focused on the development of autologous cell therapies, ... June 30, 2015, corporate highlights, and near-term milestones.  ... available at www.sedar.com ,  www.edgar.com ... "RepliCel expects to launch its RCS-01 treatment for ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... venture capital funds, investment firms and animal health companies to hear from animal ... $160 million. Several have also received licensing agreements or distribution contracts. This ...
(Date:8/27/2015)... /PRNewswire/ - Portage Biotech Inc. ("Portage") (OTC Market: ... Holding Company Limited (Biohaven), announced today that dosing ... BHV-0223, a glutamate modulating agent. Biohaven filed an ... obtained clearance from the U.S. Food and Drug ... holds 54% equity interest in Biohaven, a private ...
Breaking Biology Technology:Biopreservation Market Worth 3,731.03 Million USD by 2020 2Biopreservation Market Worth 3,731.03 Million USD by 2020 3Biopreservation Market Worth 3,731.03 Million USD by 2020 4Biopreservation Market Worth 3,731.03 Million USD by 2020 5RepliCel Reports Second Quarter 2015 Financial Results 2RepliCel Reports Second Quarter 2015 Financial Results 3RepliCel Reports Second Quarter 2015 Financial Results 4RepliCel Reports Second Quarter 2015 Financial Results 5VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 2VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 4
Cached News: